These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23174722)

  • 1. Cell cycle analysis of the CD133(+) and CD133(-) cells isolated from human colorectal cancer.
    Gharagozloo M; Mirzaei HR; Bagherpour B; Rezaei A; Kalantari H; Sanei MH; Hosseini M; Mohajeri G; Tabatabai A; Hashemi M
    J Cancer Res Ther; 2012; 8(3):399-403. PubMed ID: 23174722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer.
    Puglisi MA; Sgambato A; Saulnier N; Rafanelli F; Barba M; Boninsegna A; Piscaglia AC; Lauritano C; Novi ML; Barbaro F; Rinninella E; Campanale C; Giuliante F; Nuzzo G; Alfieri S; Doglietto GB; Cittadini A; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():55-62. PubMed ID: 19530513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
    Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
    Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis.
    Huang X; Sheng Y; Guan M
    Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
    Pitule P; Cedikova M; Daum O; Vojtisek J; Vycital O; Hosek P; Treska V; Hes O; Kralickova M; Liska V
    Biomed Res Int; 2014; 2014():432139. PubMed ID: 24864242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD 133+ and CXCR4+ colon cancer cells as a marker for lymph node metastasis.
    Silinsky J; Grimes C; Driscoll T; Green H; Cordova J; Davis NK; Li L; Margolin DA
    J Surg Res; 2013 Nov; 185(1):113-8. PubMed ID: 23777983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.
    Yano S; Tazawa H; Hashimoto Y; Shirakawa Y; Kuroda S; Nishizaki M; Kishimoto H; Uno F; Nagasaka T; Urata Y; Kagawa S; Hoffman RM; Fujiwara T
    Clin Cancer Res; 2013 Dec; 19(23):6495-505. PubMed ID: 24081978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133(-) cells, derived from a single human colon cancer cell line, are more resistant to 5-fluorouracil (FU) than CD133(+) cells, dependent on the β1-integrin signaling.
    Hongo K; Tanaka J; Tsuno NH; Kawai K; Nishikawa T; Shuno Y; Sasaki K; Kaneko M; Hiyoshi M; Sunami E; Kitayama J; Takahashi K; Nagawa H
    J Surg Res; 2012 Jun; 175(2):278-88. PubMed ID: 21601882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note.
    James MI; Howells LM; Karmokar A; Higgins JA; Greaves P; Cai H; Dennison A; Metcalfe M; Garcea G; Lloyd DM; Berry DP; Steward WP; Brown K
    PLoS One; 2015; 10(2):e0117776. PubMed ID: 25658706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.
    Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P
    Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo.
    Gemei M; Mirabelli P; Di Noto R; Corbo C; Iaccarino A; Zamboli A; Troncone G; Galizia G; Lieto E; Del Vecchio L; Salvatore F
    Cancer; 2013 Feb; 119(4):729-38. PubMed ID: 23027178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling of tumor-initiating cells in HT-29 human colorectal cancer cells.
    Lee HN; Park SH; Lee EK; Bernardo R; Kim CW
    Biochem Biophys Res Commun; 2012 Oct; 427(1):171-7. PubMed ID: 22995320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation characteristics of CD133+ cell population in colorectal cancer.
    Yu D; Zhang Y; Zou Y; Qin J; Li X; Xiao H; Tao D; Hu J; Gong J
    J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):751-6. PubMed ID: 21181366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer.
    Wang Q; Chen ZG; Du CZ; Wang HW; Yan L; Gu J
    Histopathology; 2009 Sep; 55(3):284-93. PubMed ID: 19723143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
    Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
    Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD133-positive hematopoietic progenitor cells initiate growth and metastasis of colorectal cancer cells.
    Zhang C; Zhou C; Wu XJ; Yang M; Yang ZH; Xiong HZ; Zhou CP; Lu YX; Li Y; Li XN
    Carcinogenesis; 2014 Dec; 35(12):2771-7. PubMed ID: 25269803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is CD133 a biomarker for cancer stem cells of colorectal cancer and brain tumors? A meta-analysis.
    Yang K; Chen XZ; Zhang B; Yang C; Chen HN; Chen ZX; Zhou ZG; Chen JP; Hu JK
    Int J Biol Markers; 2011; 26(3):173-80. PubMed ID: 21786247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytometric profiling of CD133+ cells in human colon 
carcinoma cell lines identifies a common core phenotype 
and cell type-specific mosaics.
    Gemei M; Di Noto R; Mirabelli P; Del Vecchio L
    Int J Biol Markers; 2013 Sep; 28(3):267-73. PubMed ID: 23709346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.